Form 8-K - Current report:
SEC Accession No. 0001193125-26-150441
Filing Date
2026-04-10
Accepted
2026-04-10 08:59:10
Documents
11
Period of Report
2026-03-31
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d345211d8k.htm   iXBRL 8-K 24309
  Complete submission text file 0001193125-26-150441.txt   134580

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20260331.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20260331_lab.xml EX-101.LAB 17233
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20260331_pre.xml EX-101.PRE 10820
15 EXTRACTED XBRL INSTANCE DOCUMENT d345211d8k_htm.xml XML 3532
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 26853293
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)